The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epilepsy and Cognitive Impairments in Alzheimer Disease
Open accessAbstract
Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures. Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors. However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models. The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs. Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD. We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with EOFAD have an 87-fold increased incidence of seizures relative to the age-matched population compared to a threefold increase in seizure incidence in LOAD individuals [6].”
From Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hyperexcitability is present in AD brain [142] and epilepsy was shown to promote plaque pathology [110].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citationPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Self-citationAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Cited by
Sorted by citations
Items 601–675 of 675
Cortical network oscillations in Alzheimer's disease: insights from rodent models
LeBeau, F. E. N. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2014.05.001
Molecular changes during the development of Alzheimer's disease
Wirz, K. T. S. (2013) · Data Archiving and Networked Services (DANS)
Varga, E. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2588
Lee, Y. (2012) · Georgetown University-Graduate School of Arts & Sciences
Érdi, P., Matsuzawa, T., John, T. T., Kiss, T., & Zalányi, L. (2017) · Springer series in bio-/neuroinformatics · doi:10.1007/978-3-319-49959-8_5
Nitrate Chimeras: A New Class of Disease Modifying Agents for the Treatment of Alzheimer's Disease
VandeVrede, L. A. (2014) · Figshare
Dhikav, V., Duraisawmy, S., & Anand, K. S. (2017) · International Journal of Epilepsy · doi:10.1016/j.ijep.2017.10.003
Rodrigo, P. P. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.137131
Memory trace superimposition impairs recall in a mouse model of ADPreprint
Poll, S., Schmid, L., Steffen, J., Wagner, J., Schmidt, B., Jackson, W. S., Schoch, S., Ehninger, D., & Fuhrmann, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/467043
Imaging Biomarkers of Acquired Epilepsies
Galovic, M., & Koepp, M. J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316257951.004
Exciting inhibition: Local regulation of synapse formation and plasticity
Kruijssen, D. L. H. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/296
Alzheimer disease and epilepsy
Михайловна, Т. А., & Датиева, В. К. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112110223
Guekht, A. B. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-22159-5_14
de Haan, W. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Kurrle, S. E., Brodaty, H., & Hogarth, R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511894534.006
Faculty Opinions recommendation of Reimagining Alzheimer's disease--an age-based hypothesis.
Борисович, Б. И. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.7896957.8252055
The Ketogenic Diet Approach as Metabolic Treatment for a Variety of Diseases
Pilla, R. (2016) · Epilepsy Journal · doi:10.4172/2472-0895.1000e010
Invertebrate and Vertebrate Models of Tauopathies
Götz, J., Ittner, L. M., Götz, N. N., Lam, H., & Nicholas, H. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00069
Epilepsy and Neurodegeneration
Retinasamy, T., & Shaikh, M. F. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_23-1
Schlein, M. L., Arituluk, Z. C., Stephen, C. A., Caldwell, G. A., Ciesla, L. M., & Caldwell, K. A. (2023) · PubMed Central · doi:10.17912/micropub.biology.000780
VIVI COM ELA A HISTÓRIA CONTADA SOBRE O CUIDADO GENUÍNO
Osório, M. M., Silveira, Y. G. B., Ribeiro, L. B., Lopes, A. C. D. S., Ferreira, M. V. R., de Medeiros, G. G., Correia, S. F., Nunes, P. T. D. P., da Silva, N. C., Pacheco, D. F., et al. (2023) · doi:10.22533/at.ed.16923270721
Rampinelli, A. P., & Vargas, A. (2023) · doi:10.22533/at.ed.16923270714
de Souza, L. S., Tsuboi, A. D. P., de Araujo, G. D. N. M., Machado, I. R., da Fonseca, C. T. M., de Mesquita, A. M. F., de Almeida, L. F., Lisboa, C. D. D., & de Paula, V. G. (2023) · doi:10.22533/at.ed.1692327077
de Araujo, G. D. N. M., Tsuboi, A. D. P., Machado, I. R., de Souza, L. S., de Mesquita, A. M. F., da Fonseca, C. T. M., Lisboa, C. D. D., de Almeida, L. F., & de Paula, V. G. (2023) · doi:10.22533/at.ed.1692327076
EXPERIÊNCIAS VIVENCIADAS POR ADOLESCENTES GRÁVIDAS
Lopes, A. C. D. S., Ferreira, M. V. R., Faria, T. S., da Silva, N. C., de Medeiros, G. G., Castro, N. H. D. S., Martins, R. M., Matos, N. B., de Oliveira, M. C. R., Neto, G. J. D. S., et al. (2023) · doi:10.22533/at.ed.16923270713
da Silva, M. H. A., Gago, L. R., da Costa, M. N. V., Peres, D. S., Magalhães, V. T. D. L., Polido, A. C. S., Neves, A. M. D. M., & Fonseca, L. M. (2023) · doi:10.22533/at.ed.16923270717
AÇÕES DE PREVENÇÃO AS DOENÇAS PREVALENTES NA COMUNIDADE INDÍGENA ILHA NO ESTADO DE RORAIMA
Alves, A. P. B., Araújo, K. A., Soares, J. P., Repetto, M., & Lima, P. A. M. (2023) · doi:10.22533/at.ed.16923270711
A UTILIZAÇÃO DO DISPOSITIVO DE TELEMETRIA E A SEGURANÇA DO PACIENTE
Lauer, R. D., Báo, A. C. P., Fraga, R. D. S., Brum, I. D., da Silva, C. R., Mariano, L., Cunha, J. R. T., Alves, M. Â. V. L., Ferreira, M. B., Tanaka, R. Y., et al. (2023) · doi:10.22533/at.ed.1692327072
CARACTERIZAÇÃO DOS CASOS DE CÂNCER EM HOMENS E MULHERES EM TRATAMENTO PALIATIVO
da Cruz, G. M. G., Ferraz, M. I. R., Lenartovicz, L. C., Hardt, J. I., Provin, C. G., Raimondo, M. L., Madureira, A. B., Harmuch, C., Dambroski, D. L., & Moreira, A. D. C. (2023) · doi:10.22533/at.ed.1692327071
NOVAS PERCEPÇÕES DA DOENÇA DE ALZHEIMER NA ERA DOS BIOMARCADORES PARA DIAGNÓSTICO
Silva, T., & Cabello, P. H. (2023) · doi:10.22533/at.ed.16923270720
Shirrafiardekani, A., Mirjalili, A., Alashwal, H., & Moustafa, A. A. (2023) · International Conference on Machine Learning and Cybernetics · doi:10.1109/icmlc58545.2023.10327966
(outdated draft) Somatostatin and the pathophysiology of Alzheimer’s diseasePreprint
Almeida, V. N. (2024) · Qeios · doi:10.32388/goy6dk.2
Michaud, F., Francavilla, R., Topolnik, D., Iloun, P., Tamboli, S., Calon, F., & Topolnik, L. (2024) · eLife · doi:10.7554/elife.95412.2
Michaud, F., Francavilla, R., Topolnik, D., Iloun, P., Tamboli, S., Calon, F., & Topolnik, L. (2024) · eLife · doi:10.7554/elife.95412.3.sa2
Epilepsy and Neurodegeneration
Retinasamy, T., & Shaikh, M. F. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_23
The role of the basal forebrain in the pathogenesis of Alzheimer’s disease
Kitchigina, V. F., Popova, I. Y., & Shubina, L. (2024) · Журнал высшей нервной деятельности им И П Павлова · doi:10.31857/s0044467724050026
Dejuk, M., Lekoubou, A., Saggi, S. S., Agrawal, A., Bonilha, L., Chinchilli, V. M., & Ovbiagele, B. I. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123332
Oluwatunase, G. O., Okwute, P. G., Asafa, O. O., Oyeniran, D. A., & Ogenetega, O. B. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008845
Ghatak, S., & Lipton, S. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_18
Systemic Review on Drug Repurposing: Anti-Epileptic Drug in the Treatment of Alzheimer's Disease
Saif, A., Siddiqui, M. A. I., & Aziz, A. (2025) · International Journal of Research in Medical Sciences & Technology · doi:10.37648/ijrmst.v19i01.004
Seizures in a Bang-Sensitive Epilepsy Model Impact Associative Learning in Drosophila LarvaePreprint
Gammon, K. T., Cho, S., & Reynolds, E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671221
Epileptic seizures in patients with Alzheimer’s disease
Бурд, С. Г., Bogolepova, A. N., Лебедева, А. В., Rubleva, Y. V., Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., Gileva, E. A., Pantina, N. V., Kovaleva, I. I., et al. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512511136
Development of presynaptic calcium dynamics and short-term plasticity in the SC-Ca1 synapse
Scullin, C. S. (2010) · UNM’s Digital Repository (University of New Mexico)
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573215
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573209
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573197
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573212
van Nifterick, A. M., Gouw, A. A., van Kesteren, R. E., Scheltens, P., Stam, C. J., & de Haan, W. (2022) · Figshare · doi:10.6084/m9.figshare.20374707
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573203
Kim, K.-R., Kim, Y., Jeong, H.-J., Kang, J.-S., Lee, S. H., Kim, Y., Lee, S.-H., & Ho, W.-K. (2021) · Figshare · doi:10.6084/m9.figshare.14344403
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A. I., Pathan, J. L., Davidson, S., Wilson, A. M., Keene, C. D., de la Iglesia, H. O., Jayadev, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573218
ZCCHC17: a target for synaptic dysfunction and neuronal excitability in Alzheimer’s disease
Klub, B. A., Teich, A. F., & Cortese, G. P. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1737060
Barger, S. W., & Moerman, A. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1781541
Alcantara‐Gonzalez, D., Santiago, E., & Peña‐Ortega, F. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1738954
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
Mitochondria, neurosteroids and biological rhythms : implications in health and disease states
Grimm, A. (2015) · theses.fr (ABES) · doi:10.70675/8aac5aa9z77cdz49bdz9cf5z0ff0b5dd0f84
Association of the APP rs463946 Polymorphism with Epilepsy Risk: A Case-Control Study from Georgia
Vashadze, S., Beridze, M., Kvirkvelia, N., Gorgiladze, K., & Kekenadze, M. (2026) · Georgian Medical Journal · doi:10.66636/gmj.v1.i2.a110
mTORC2-Na v 1.2 signaling drives early hyperexcitability in Alzheimer’s disease mouse model
Dvorak, N. M., & Noebels, J. L. (2026) · Channels · doi:10.1080/19336950.2026.2687246
Yang, M., Ouyang, X., Gautam, S., Singleton, M., Davydzenka, V., Zhang, J., & Li, Y. (2026) · Molecular Brain · doi:10.1186/s13041-026-01332-z
Vaknalli, R. N., Addo-Osafo, K., Chenchu, V. S. M., Hwang, K., de Vicente, M., Bragin, A., & Vossel, K. A. (2026) · Research Square · doi:10.21203/rs.3.rs-10385398/v1
da Silva, A. M. P., Júnior, D. V. D. S. L., Cardoso, L. J. C., Tudella, G. C. N., Lee, A. M., da Costa, M. M., Cukiert, C. M., Noleto, G. S., Santos, D. H., & Perry, G. L. (2026) · Seizure · doi:10.1016/j.seizure.2026.08.026
APOE-Glia Crosstalk in Epilepsy: Mechanisms, Controversies, and Therapeutic Perspectives
Zhang, M., Song, J.-H., Li, X., Wang, M., Zhang, Y.-F., & Li, Y. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s625961
Association of apolipoprotein E gene with risk, cognition, and prognosis of epilepsy
Liu, S., Fan, L., He, Z., Yi, T., Wang, J., Zhao, J., Sander, J. W. A. S., Zhou, D., & Li, J. (2026) · Human Genetics · doi:10.1007/s00439-026-02876-9
Parvalbumin cell state dynamics regulate gamma oscillations and are disrupted in Alzheimer’s disease
Ma, K., Park, K., Honma, P. S., Zhang, Y., Brady, E. S., Qiu, Y., Opitz-Araya, X., Ting, J. T., Levi, B. P., Akassoglou, K., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.025
Self-citationImpact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease
Sierksma, S. R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121220ss
Metadata
- Authors
- Palop, J. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Palop, Jorge J.
- ORCID
- Palop, Jorge J.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-04-01
- Volume
- 66
- Issue
- 4
- Pages
- 435
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2812914
- OpenAlex
- W2098676436
- Cited by
- 684
- References
- 47
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 47 · 2023: 50 · 2022: 38 · 2021: 46 · 2020: 34 · 2019: 47 · 2018: 33 · 2017: 40 · 2016: 47 · 2015: 42 · 2014: 43 · 2013: 41 · 2012: 39
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG023501, P50AG023501)
- National Institute of Neurological Disorders and Stroke (R01NS041787, NS041787)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- Alzheimer's disease, epilepsy, cognitive impairment, amyloid-beta, epileptiform activity, presenilin mutations, amyloid precursor protein, APOE ε4, early-onset Alzheimer's disease, transgenic mouse model, antiepileptic drugs
- MeSH terms
- Alzheimer Disease, Amnesia, Animals, Brain, Cognition Disorders, Disease Models, Animal, Electroencephalography, Epilepsy, Genetic Carrier Screening, Hippocampus, Humans, Mice, Transgenic, Nerve Net, Neural Inhibition, Synaptic Transmission, Picrotoxin, Amyloid beta-Peptides, tau Proteins, GABA Antagonists, Dentate Gyrus, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
